PQUS0.070%
as of Sep 1
MCK
GrowthMCKESSON CORP
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers.
Close · 3M
+2.50%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals7
Win rate100% (7/7)
Avg buy return+14.26%
PQUS · New entry · 1d
weight 0 → 0.040% (new)·stock up 9.4% in the 30 days before
Aug 21·entry $858.90·now $921.38Drifting
+7.27%
since Aug 21
PQUS · Exit · 1d
weight 0.070% → 0 (exited)·stock down 5.5% in the 30 days before
Jun 4·entry $756.95·now $921.38
+21.72%
since Jun 4
PQUS · New entry · 1d
weight 0 → 0.110% (new)·stock down 15.7% in the 30 days before
May 10·entry $725.17·now $921.38Chased
+27.06%
since May 10
AIEQ · Exit · 1d
weight 0.050% → 0 (exited)·stock up 9.6% in the 30 days before
Sep 1·entry $906.77·now $921.38
+1.61%
since Sep 1
AIEQ · New entry · 1d
weight 0 → 0.050% (new)·stock up 13.5% in the 30 days before
Aug 2·entry $827.14·now $921.38Chased
+11.39%
since Aug 2
AIEQ · Exit · 1d
weight 0.780% → 0 (exited)·stock down 9.7% in the 30 days before
May 30·entry $734.82·now $921.38
+25.39%
since May 30
AIEQ · Weight decrease · 2d
weight 0.820% → 0.800% (-0.020 pp)·stock down 8.4% in the 30 days before
May 22·entry $766.08·now $921.38
+20.27%
since May 22
AIEQ · Weight increase · 3d
weight 0.760% → 0.800% (+0.040 pp)·stock down 12.3% in the 30 days before
May 17·entry $775.97·now $921.38Chased
+18.74%
since May 17
AIEQ · Weight increase · 2d
weight 0.760% → 0.780% (+0.020 pp)·stock down 12.3% in the 30 days before
May 15·entry $760.57·now $921.38Chased
+21.14%
since May 15
AIEQ · Weight decrease · 2d
weight 0.870% → 0.780% (-0.090 pp)·stock down 13.4% in the 30 days before
May 7·entry $754.76·now $921.38
+22.08%
since May 7
AIEQ · Sudden change · 1d
weight 0.380% → 0.870% (+0.490 pp)·stock down 6.7% in the 30 days before
May 3·entry $807.85·now $921.38
+14.05%
since May 3
AMOM · Exit · 1d
weight 1.420% → 0 (exited)·stock down 8.6% in the 30 days before
May 4·entry $807.85·now $921.38
+14.05%
since May 4
AMOM · Weight decrease · 3d
weight 1.490% → 1.420% (-0.070 pp)·stock down 6.7% in the 30 days before
May 1·entry $814.02·now $921.38
+13.19%
since May 1
AMOM · Weight decrease · 2d
weight 1.490% → 1.430% (-0.060 pp)·stock down 5.8% in the 30 days before
Apr 30·entry $815.20·now $921.38
+13.03%
since Apr 30
AMOM · Weight decrease · 2d
weight 1.500% → 1.450% (-0.050 pp)·stock down 4.1% in the 30 days before
Apr 27·entry $828.32·now $921.38
+11.23%
since Apr 27
AMOM · Weight decrease · 7d
weight 1.650% → 1.490% (-0.160 pp)·stock down 5.4% in the 30 days before
Apr 22·entry $829.23·now $921.38
+11.11%
since Apr 22
AMOM · Weight decrease · 7d
weight 1.660% → 1.520% (-0.140 pp)·stock down 4.9% in the 30 days before
Apr 21·entry $842.25·now $921.38
+9.40%
since Apr 21
AMOM · Weight decrease · 7d
weight 1.700% → 1.540% (-0.160 pp)·stock down 4.4% in the 30 days before
Apr 20·entry $859.04·now $921.38
+7.26%
since Apr 20
+6.35%
since Apr 17
+6.23%
since Apr 16
+6.71%
since Apr 15
+6.44%
since Apr 10
+5.49%
since Apr 9
+5.76%
since Apr 8
+7.56%
since Apr 7
+5.62%
since Apr 1
AMOM · Weight increase · 3d
stock down 12.9% in the 30 days before
Mar 30·entry $860.19·now $921.38Drifting
+7.11%
since Mar 30
AMOM · Weight increase · 2d
stock down 11.7% in the 30 days before
Mar 27·entry $860.16·now $921.38Drifting
+7.12%
since Mar 27
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
Buffett-style framework
Fails the frameworkas of May 18
Several AI ETFs, specifically AIEQ and PQUS, have shown recent positive activity, either increasing weight or initiating new positions in McKesson Corp, while AMOM exited. This contrasts with the framework's "Fail" verdict, which stems from insufficient data to confirm the company's long-term financial health and establish a margin of safety for a value investment.
- Circle of CompetenceMcKesson operates in the stable and essential pharmaceutical distribution industry, allowing for reasonably predictable long-term cash flow projections despite regulatory complexities.
- Economic MoatMcKesson possesses a strong economic moat derived from its immense scale, efficient logistics, and high switching costs for customers in the concentrated pharmaceutical distribution market.
- ManagementWithout access to shareholder letters or detailed capital allocation reports, assessing management's candor, capital allocation discipline, or skin in the game is not possible with the provided data.
- Financial HealthWhile the most recent ROE of 39.43% is excellent, the provided data is insufficient to assess the 10-year average ROE, historical operating margins, debt manageability, or owner earnings trend.
- Margin of SafetyWithout a conservative estimate of intrinsic value based on projected owner earnings, it is not possible to determine if the current market price offers a sufficient margin of safety.
McKesson Corp. operates in a predictable industry with a strong economic moat based on scale and distribution network. However, the lack of comprehensive historical financial data prevented a full assessment of its financial health and long-term owner earnings. Crucially, without a conservative intrinsic value estimate, a margin of safety could not be determined, leading to a "Fail" verdict within this framework.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.